Exhibit 5.1 and Exhibit 23.1
ROGER D. LINN
July 27, 2000
Board of Directors
Dragon Pharmaceutical Inc.
543 Granville Street, Suite 1200
Vancouver, BC V6C 1X8
Re: Common Stock of Dragon Pharmaceutical Inc.
Registered on Form SB-2 filed May 15, 2000
Gentlemen:
We act as securities counsel to Dragon Pharmaceutical Inc. (the
"Company"), a Florida corporation, in connection with the registration under the
Securities Act of 1933, as amended (the "Securities Act"), of approximately
10,958,000 shares of the Company's Common Stock (the "Shares"), all of which is
outstanding or issuable upon the exercise of outstanding warrants and resold, as
further described in a registration statement on Form SB-2 filed under the
Securities Act (the "Registration Statement") on May 15, 2000.
For the purpose of rendering this opinion, we examined originals or
photostatic copies of such documents as we deemed to be relevant. In conducting
our examination, we assumed, without investigation, the genuineness of all
signatures, the correctness of all certificates, the authenticity of all
documents submitted to us as originals, the conformity to original documents of
all documents submitted to us as certified or photostatic copies and the
authenticity of the originals of such copies, and the accuracy and completeness
of all records made available to us by the Company. In addition, in rendering
this opinion, we assumed that the Shares will be offered in the manner and on
the terms identified or referred to in the prospectus, including all amendments
thereto.
Our opinion is limited solely to matters set forth herein. Attorneys
practicing in this firm are admitted to practice in the State of California and
we express no opinion as to the laws of any other jurisdiction other than the
laws of the United States. For purposes of this Opinion Letter, it is assumed
that to the extent the validity of share issuances is interpreted pursuant to
laws of the State of Florida, such interpretation would be consistent with the
law of the State of California.
<PAGE>2
Based upon and subject to the foregoing, after giving due regard to such
issues of law as we deemed relevant, and assuming that (i) the Registration
Statement becomes and remains effective, and the prospectus which is part
thereof (the "Prospectus"), and the Prospectus delivery procedures with respect
thereto, fulfill all of the requirements of the Securities Act, throughout all
periods relevant to the opinion, and (ii) all offers and sales of the Shares
have been and will be made in compliance with the securities laws of the states,
having jurisdiction thereof, we are of the opinion that the Shares, offered by
the Selling Shareholders have been, and the Shares to be issued upon the
exercise of Warrants for adequate consideration will be, validly issued, fully
paid, and non-assessable.
We hereby consent in writing to the use of our opinion as an exhibit to
the Registration Statement and any amendment thereto.
Sincerely yours,
/s/ BARTEL ENG LINN & SCHRODER
